First-Line ART Failure
Predicting Virological Failure with Immunological Criteria in First Line ART Patients in a Resource Poor Setting
10
Factors for nonadherence to first line art therapy in a cohort of Human Immunodeficiency Virus positive adult patients
7
First-line antiretroviral treatment failure and associated factors in HIV patients at University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia
6
Retention in care and virological failure among adult HIV+ patients on second line ART in Rwanda: a national representative study
9
Schistosomiasis and HIV 1 viral load in HIV infected outpatients with immunological failure in Tanzania: a case control study
7
Estimation of Clinical, Immunological and Virological Failure of First Line Antiretroviral Treatment in Kinshasa, Democratic Republic of Congo
8
Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study
8
Evaluation of adverse effect of second line ART in PL HIV patients treated by second line ART
8
Determinants of first line antiretroviral therapy treatment failure among adult patients on ART at central Ethiopia: un matched case control study
13
Incidence and predictors of second line antiretroviral treatment failure among adults living with HIV in Amhara region: a multi centered retrospective follow up study
9
Predictors of treatment failure, time to switch and reasons for switching to second line antiretroviral therapy in HIV infected children receiving first line anti-retroviral therapy at a Tertiary Care Hospital in Ethiopia
9
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
7
Involvement of the Genetic Diversity of HIV 1 in the Virological Treatment Failure of First Line Antiretroviral in Kinshasa
11
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
6
A study of profile of patients failing first line NACO recommended ART
7
SESOTHO trial (“Switch Either near Suppression Or THOusand”) – switch to second line versus WHO guided standard of care for unsuppressed patients on first line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel group, open label, randomized clinical trial in Lesotho, Southern Africa
9
<p>Predictors of Clinical and Immunological Failure Among Patients on First-Line Antiretroviral Therapy (ART) in Southwest Ethiopia</p>
10
Reasons for first line ART modification over the years during the ART scale up in Uganda
8
Comparision and evaluation of the clinical features of the patients of ART 1 failure who have started ART 2 medication
9
Viral load detection and management on first line ART in rural Rwanda
9